• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Hillhurst Bio

Wednesday, June 05, 2024
Company Presentation Theater 2
Hillhurst Bio is a clinical stage company developing novel oral liquid drugs, using its proprietary GLASS platform to enable the oral delivery of medicines that previously could only be delivered by inhalation. Our lead drug product, HBI-002, targets treatment of sickle cell disease and Parkinson’s disease, and our follow-on non-opioid drug, HBI-201, targets acute pain.
Hillhurst Bio
Company Website: http://www.hillhurstbio.com
Lead Product in Development: HBI-002
Number Of Unlicensed Products (For Which You Are Seeking Partners): Two

Company HQ City

Montrose

Company HQ State

CA 91020

Company HQ Country

United States

CEO/Top Company Official

Andrew Gomperts, JD MBA

Development Phase of Primary Product

Phase II
Primary Speaker
Andrew Gomperts, JD
President and CEO
Hillhurst Bio
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS